Diagnostics, therapy and aftercare in the field of malignant haematology includes, among other things
- Diagnosis of acute leukaemias with treatment of patients with acute myeloid leukaemia, especially older patients or patients not eligible for transplantation
- Diagnosis and treatment of diseases of the lymphatic system
(Hodgkin's lymphomas and non-Hodgkin's lymphomas such as mantle cell lymphoma, marginal zone lymphoma, follicular lymphoma, Waldenström's disease) - Multiple myeloma
Multiple myeloma is a disease of the plasma cells, a special type of blood cell. In multiple myeloma, the plasma cells in the bone marrow change and multiply uncontrollably. Multiple myeloma is therefore also known colloquially as "bone marrow cancer". The degenerated plasma cells form multiple cell clusters in the bone marrow, prevent the normal formation of blood cells and destroy the bones. - Chronic lymphocytic leukaemia (CLL)
Chronic lymphocytic leukaemia (CLL) is a cancer of the lymphatic system, including the lymph nodes, spleen and bone marrow. CLL is one of the most common blood cancers in adults. The incidence of the disease increases with age: around 9 out of 10 people affected are older than 55. For many patients, regular check-ups are sufficient at the beginning - only when the CLL causes symptoms is therapy used: this can often push the disease back over many years. - Chronic myeloid leukaemia (CML)
Chronic myeloid leukaemia, or CML for short, is a malignant disease of the bone marrow in which too many white blood cells are produced. According to the classification of the World Health Organisation, CML belongs to the myeloproliferative neoplasms (MPN), but plays a special role due to its genetic cause. The development of drugs that are precisely tailored to the cause of the disease has revolutionised treatment, meaning that patients can now usually lead a normal everyday life with a good quality of life. Current studies are currently investigating whether a medical cure is also possible. - Myeloproliferative neoplasms
(MPN such as polycythaemia vera, essential thrombocythaemia and primary myelofibrosis) - Myelodysplastic syndromes (MDS)
The term myelodysplastic syndromes (MDS) covers a range of bone marrow diseases in which too few functional blood cells are formed. The individual forms of MDS differ in terms of their course, treatment options and the risk of developing into acute leukaemia. The disease is one of the most common malignant blood disorders in adults and mainly occurs in patients over the age of 60. Even though MDS cannot yet be cured with medication, the diagnosis and treatment options have been continuously improved in recent years thanks to new scientific findings. - Systemic mastocytosis